How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,271 results for

"grant funding" or "obtaining grants" or "getting grants" or "grant awards" or (grants and "how to")

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17761. Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis

ID Numbers: 95230 Stanford IRB Number 4593 Other Grant ( Other Grant/Funding Number: Stanford University Department of Anesthesia ) First Posted: September 16, 2005 Last Update Posted: April 11, 2011 Last Verified: April 2011 Keywords provided by Stanford University: Sepsis Adrenal Insufficiency Hydrocortisone Gene Expression Microarray RNA Critically Ill Additional relevant MeSH terms: Layout table for MeSH terms Sepsis Toxemia Adrenal Insufficiency Infection Systemic Inflammatory Response

2005 Clinical Trials

17762. Stereotactic Radiotherapy (SRT) Liver (COLD 1)

Frame: assessment: pre-treatement, 1, 3, 6,12 months post ] To evaluate changes in liver function following SRT. [ Time Frame: 3 to 12 months ] To evaluate patterns of breathing at and during RT. [ Time Frame: during radiation treatment only ] To develop more confidence in a revised normal tissue complication probability (NTCP) model for radiation induced liver toxicity and collect preliminary data to determine how the liver responds to radiation. [ Time Frame: at 3 months post RT ] To determine (...) for additonal information Responsible Party: University Health Network, Toronto ClinicalTrials.gov Identifier: Other Study ID Numbers: UHN REB 03-0295-C ASCO Clinical Research Grant First Posted: September 9, 2005 Last Update Posted: September 25, 2018 Last Verified: September 2018 Additional relevant MeSH terms: Layout table for MeSH terms Neoplasms Neoplasm Metastasis Liver Neoplasms Neoplastic Processes Pathologic Processes Digestive System Neoplasms Neoplasms by Site Digestive System Diseases Liver

2005 Clinical Trials

17763. HOME Study (Health Outcomes and Measures of the Environment Study)

: Publications of Results: Other Publications: Bowers K, Khoury J, Sucharew H, Xu Y, Chen A, Lanphear B, Yolton K. Early infant attention as a predictor of social and communicative behavior in childhood. International Journal of Behavioral Development 2018:0165025418797001. Layout table for additonal information Responsible Party: National Institute of Environmental Health Sciences (NIEHS) ClinicalTrials.gov Identifier: Other Study ID Numbers: 11261-CP-001 MDLTS0008-18 ( Other Grant/Funding Number: HUD

2005 Clinical Trials

17764. Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals

Measures : adherence to key quality indicators for antibiotic use in lower respiratory tract infections (indicators were developed from current [inter]national guideline recommendations and a systematic review of the literature) Secondary Outcome Measures : cost process evaluation: how well was the intervention performed length of hospital stay in-hospital mortality Intensive Care Unit (ICU)-transfer 30 day re-admission rate Eligibility Criteria Go to Information from the National Library of Medicine (...) ClinicalTrials.gov Identifier: Other Study ID Numbers: AGAR-2001-1 ZonMw grant no. 2300.0024 First Posted: August 12, 2005 Last Update Posted: September 27, 2005 Last Verified: August 2002 Keywords provided by Radboud University: quality of care antibiotic use intervention lower respiratory tract infections Community acquired Pneumonia Acute Exacerbation of Chronic Bronchitis or COPD Additional relevant MeSH terms: Layout table for MeSH terms Pneumonia Bronchitis Bronchitis, Chronic Lung Diseases Respiratory

2005 Clinical Trials

17765. Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice

, Nijmegen, The Netherlands Principal Investigator: Erik Bischoff, MD Department of General Practice, Radboud University, Nijmegen, The Netherlands More Information Go to Publications: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: E. Bischoff, MD MSc, Radboud University ClinicalTrials.gov Identifier: Other Study ID Numbers: MONC95582 ZonMw grant: 945.04.230 ( Other Grant/Funding Number: ZonMw (...) ) Picasso grant: 005.2004 ( Other Grant/Funding Number: Picasso ) CMO: 2004/249 ( Other Identifier: Medical Ethics Committee ) First Posted: August 10, 2005 Last Update Posted: November 22, 2011 Last Verified: November 2011 Keywords provided by E. Bischoff, Radboud University: chronic obstructive pulmonary disease (COPD) self-management practice nurse cost-effectiveness randomized controlled trial Additional relevant MeSH terms: Layout table for MeSH terms Lung Diseases Lung Diseases, Obstructive

2005 Clinical Trials

17766. S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer

for investigator information Principal Investigator: Syma Iqbal Southwest Oncology Group More Information Go to Layout table for additonal information Responsible Party: National Cancer Institute (NCI) ClinicalTrials.gov Identifier: Other Study ID Numbers: NCI-2012-03180 S0413 U01CA32102 ( Other Grant/Funding Number: US NIH Grant/Contract Award Number ) CDR0000409575 ( Registry Identifier: PDQ (Physician Data Query) ) First Posted: February 8, 2005 Last Update Posted: January 17, 2013 Last Verified: January (...) (NCI) Information provided by (Responsible Party): National Cancer Institute (NCI) Study Details Study Description Go to Brief Summary: This phase II trial is studying how well lapatinib works in treating patients with locally advanced or metastatic stomach cancer. Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth Condition or disease Intervention/treatment Phase Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed

2005 Clinical Trials

17767. Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving the drugs in different ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well isolated hepatic perfusion with melphalan followed by combination chemotherapy works in treating patients with unresectable liver metastases from colorectal cancer. Condition or disease Intervention/treatment Phase Colorectal Cancer Metastatic Cancer Drug: FOLFOX regimen Drug: fluorouracil (...) anticoagulation therapy No concurrent immunosuppressive drugs Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00103298 Locations Layout table for location information United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support

2005 Clinical Trials

17768. Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

) Investigators Layout table for investigator information Study Chair: Edward Hirschowitz, MD Lucille P. Markey Cancer Center at University of Kentucky More Information Go to Publications of Results: Layout table for additonal information Responsible Party: Edward Hirschowitz, Principal Investigator, University of Kentucky ClinicalTrials.gov Identifier: Other Study ID Numbers: CDR0000410830 UKMC-IRB-0391-F2R ( Other Identifier: IRB ) UKMC-CTRF-G-01-009 ( Other Grant/Funding Number: Cancer Treatment Research (...) , 2017 Last Update Posted : April 4, 2017 Sponsor: Edward Hirschowitz Collaborator: National Cancer Institute (NCI) Information provided by (Responsible Party): Edward Hirschowitz, University of Kentucky Study Details Study Description Go to Brief Summary: RATIONALE: Vaccines made from a person's white blood cells and allogeneic tumor cells may make the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating

2005 Clinical Trials

17769. Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia

Philadelphia, Pennsylvania, United States, 19107 Sponsors and Collaborators Thomas Jefferson University Investigators Layout table for investigator information Principal Investigator: Marlind A Stiles, D.M.D. Thomas Jefferson University, Jefferson Headache Center More Information Go to Layout table for additonal information Responsible Party: Thomas Jefferson University ClinicalTrials.gov Identifier: Other Study ID Numbers: MAS/LAM101 H92001 ( Other Grant/Funding Number: GlaxoSmithKline ) First Posted (...) First Posted : June 3, 2014 Last Update Posted : June 3, 2014 Sponsor: Thomas Jefferson University Information provided by (Responsible Party): Thomas Jefferson University Study Details Study Description Go to Brief Summary: This research study will look at the safety (e.g., the occurrence of side effects) and efficacy (how well the drug works in reducing trigeminal neuralgia attacks) of a drug called lamotrigine in adults with trigeminal neuralgia. Condition or disease Intervention/treatment Phase

2005 Clinical Trials

17770. Evaluation of an Intervention Model for Family Crisis and Support

H133A020516 ( Other Grant/Funding Number: NIDRR ) H133A070036 ( Other Grant/Funding Number: NIDRR ) First Posted: September 20, 2005 Last Update Posted: July 31, 2013 Last Verified: July 2013 Keywords provided by Virginia Commonwealth University: brain injury, family treatment Additional relevant MeSH terms: Layout table for MeSH terms Wounds and Injuries Brain Injuries Brain Injuries, Traumatic Brain Injury, Chronic Brain Diseases Central Nervous System Diseases Nervous System Diseases Craniocerebral (...) provided by (Responsible Party): Virginia Commonwealth University Study Details Study Description Go to Brief Summary: To learn more about how a family treatment program helps people after brain injury. Specifically, do families feel better and function better after going through the program, and do patients feel better and function better after going through the program. Condition or disease Intervention/treatment Traumatic Brain Injury Brain Injury, Chronic Behavioral: Brain Injury Family

2005 Clinical Trials

17771. Soy Protein and Breast Cancer Risk Reduction

Identifier (NCT Number): Layout table for additonal information Responsible Party: The University of Texas Medical Branch, Galveston ClinicalTrials.gov Identifier: Other Study ID Numbers: 02-422 Army's HSRRB log no. A-10926 ( Other Identifier: USA MRMC Human Research Protection Office (HRPO) ) UTMB GCRC 533 ( Other Identifier: UTMB ITSCRC ) DAMD17-01-1-0417 ( Other Grant/Funding Number: USA MRMC ) First Posted: September 20, 2005 Last Update Posted: March 15, 2019 Last Verified: March 2019 Individual

2005 Clinical Trials

17772. Childhood Origins of Asthma (COAST)

interaction that needs to occur at a critical time period in the development of the immune system or the lung. It remains to be firmly established, however, how any one or all of these factors, either independently or interactively, influence the development of childhood asthma. Thus, our efforts to determine and define the importance of these three factors to asthma pathogenesis are the focus and goal of this current grant application. Condition or disease Asthma Allergy Detailed Description: No more

2005 Clinical Trials

17773. Breastfeeding, Antiretroviral, and Nutrition Study

Identifier (NCT Number): Layout table for additonal information Responsible Party: Dr. Denise Jamieson, CDC ClinicalTrials.gov Identifier: Other Study ID Numbers: CDC-NCCDPHP-3946 U48CCU409660 ( Other Grant/Funding Number: U.S. Centers for Disease Control and Prevention ) PA 04003 SIP 26-04 ( Other Grant/Funding Number: U.S. Centers for Disease Control and Prevention ) First Posted: September 14, 2005 Last Update Posted: April 23, 2010 Last Verified: April 2010 Keywords provided by Centers for Disease

2005 Clinical Trials

17774. Increasing Physical Activity Among Overweight Women With Mobility Disabilities.

( Other Grant/Funding Number: CDC/NCBDDD/DHDD ) First Posted: September 14, 2005 Last Update Posted: July 28, 2011 Last Verified: July 2011 Keywords provided by Centers for Disease Control and Prevention: obesity, mobility limitations, women, physical activity Additional relevant MeSH terms: Layout table for MeSH terms Overweight Mobility Limitation Body Weight Signs and Symptoms

2005 Clinical Trials

17775. Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

for investigator information Principal Investigator: Jonathan Strosberg, MD H. Lee Moffitt Cancer Center & Research Institute / University of South Florida More Information Go to Additional Information: Layout table for additonal information Responsible Party: H. Lee Moffitt Cancer Center and Research Institute ClinicalTrials.gov Identifier: Other Study ID Numbers: MCC-13449 R21 CA10135 ( Other Grant/Funding Number: NCI ) XEL390 ( Other Identifier: Roche ) 2005-0729 ( Other Identifier: Pfizer ) First Posted

2005 Clinical Trials

17776. Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

and Research Institute More Information Go to Publications of Results: Layout table for additonal information Responsible Party: H. Lee Moffitt Cancer Center and Research Institute ClinicalTrials.gov Identifier: Other Study ID Numbers: MCC-13920 CA101324 ( Other Grant/Funding Number: NIH ) CA84488 ( Other Grant/Funding Number: NIH ) First Posted: January 7, 2005 Last Update Posted: August 16, 2013 Last Verified: July 2013 Keywords provided by H. Lee Moffitt Cancer Center and Research Institute: stage IV (...) cells. Giving tretinoin together with interleukin-2 may kill more tumor cells. PURPOSE: This randomized phase II trial is studying how well giving three different doses of tretinoin together with interleukin-2 works in treating patients with stage IV kidney cancer. Condition or disease Intervention/treatment Phase Kidney Cancer Drug: IL-2 Drug: ATRA Phase 2 Detailed Description: OBJECTIVES: Primary Determine the ratio of dendritic cells (DC) to circulating immature cells (ImC) before and after

2005 Clinical Trials

17777. Trial of DMXB-A in Schizophrenia

Care System, Denver, CO More Information Go to Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: VA Office of Research and Development ClinicalTrials.gov Identifier: Other Study ID Numbers: 57710-2 VISN 19 MIRECC ( Other Grant/Funding Number: VA ) First Posted: December 24, 2004 Last Update Posted: December 7, 2015 Last Verified: December 2015 Keywords provided by VA Office of Research

2004 Clinical Trials

17778. DHA and X-Linked Retinitis Pigmentosa

information Responsible Party: Dennis Hoffman, Senior Research Scientist (Retina Foundation of the Southwest), Retina Foundation of the Southwest ClinicalTrials.gov Identifier: Other Study ID Numbers: 2543 FD-R-002543 C-TX02-0704-0274 ( Other Grant/Funding Number: Foundation Fighting Blindness ) First Posted: December 28, 2004 Results First Posted: March 17, 2015 Last Update Posted: March 17, 2015 Last Verified: March 2015 Keywords provided by Dennis Hoffman, Retina Foundation of the Southwest: retina

2004 Clinical Trials

17779. A Safety Study of Sutherlandia Frutescens, a South African Medicinal Plant, in Healthy Adult Volunteers

Other Study ID Numbers: TICIPS-001 ( Other Grant/Funding Number: NCCIH ) First Posted: September 14, 2006 Last Update Posted: September 30, 2016 Last Verified: September 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Undecided Keywords provided by University of Missouri-Columbia: Lessertia frutescens Sutherlandia frutescens Phase 1 clinical trial Human safety study

2005 Clinical Trials

17780. Studies of Organ Transplantation in Animals and Man

of Surgery More Information Go to Publications: Layout table for additonal information Responsible Party: Michael Mauer, MD ClinicalTrials.gov Identifier: Other Study ID Numbers: 8107M00116 NIH 2P01-DK13083-38 ( Other Grant/Funding Number: NIH ) First Posted: September 12, 2005 Last Update Posted: December 11, 2014 Last Verified: December 2014 Keywords provided by University of Minnesota - Clinical and Translational Science Institute ( Michael Mauer, MD ): Diabetic Nephropathy Kidney Transplant Pancreas

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>